Rankings
▼
Calendar
HROW Q4 2024 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q4 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$67M
+83.8% YoY
Gross Profit
$53M
78.8% margin
Operating Income
$13M
19.3% margin
Net Income
$7M
10.1% margin
EPS (Diluted)
$0.19
QoQ Revenue Growth
+35.7%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$55M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$389M
Total Liabilities
$320M
Stockholders' Equity
$70M
Cash & Equivalents
$47M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$67M
$36M
+83.8%
Gross Profit
$53M
$25M
+110.3%
Operating Income
$13M
-$5M
+364.6%
Net Income
$7M
-$9M
+174.1%
Revenue Segments
Other Revenue
$687,000
100%
← FY 2024
All Quarters
Q1 2025 →